130 related articles for article (PubMed ID: 15048705)
21. Inclusion of Brefeldin A during dendritic cell isolation allows in vitro detection of cross-presented self-antigens.
Benke D; Krüger T; Lang A; Hamilton-Williams EE; Kurts C
J Immunol Methods; 2006 Mar; 310(1-2):12-9. PubMed ID: 16510151
[TBL] [Abstract][Full Text] [Related]
22. Rapid constitutive generation of a specific peptide-MHC class II complex from intact exogenous protein in immature murine dendritic cells.
Colledge L; Bennett CL; Reay PA; Blackburn CC
Eur J Immunol; 2002 Nov; 32(11):3246-55. PubMed ID: 12555670
[TBL] [Abstract][Full Text] [Related]
23. MHC class I-associated presentation of exogenous peptides is not only enhanced but also prolonged by linking with a C-terminal Lys-Asp-Glu-Leu endoplasmic reticulum retrieval signal.
Wang L; Wu YZ; Chen A; Zhang JB; Yang Z; Niu W; Geng M; Ni B; Zhou W; Zou LY; Jiang M
Eur J Immunol; 2004 Dec; 34(12):3582-94. PubMed ID: 15495159
[TBL] [Abstract][Full Text] [Related]
24. Biodegradable nanoparticles containing TLR3 or TLR9 agonists together with antigen enhance MHC-restricted presentation of the antigen.
Lee YR; Lee YH; Im SA; Yang IH; Ahn GW; Kim K; Lee CK
Arch Pharm Res; 2010 Nov; 33(11):1859-66. PubMed ID: 21116790
[TBL] [Abstract][Full Text] [Related]
25. Impaired lung dendritic cell migration and T cell stimulation induced by immunostimulatory oligonucleotides contribute to reduced allergic airway inflammation.
Constabel H; Stankov MV; Hartwig C; Tschernig T; Behrens GM
J Immunol; 2009 Sep; 183(5):3443-53. PubMed ID: 19667097
[TBL] [Abstract][Full Text] [Related]
26. Baccatin III, a synthetic precursor of taxol, enhances MHC-restricted antigen presentation in dendritic cells.
Lee YH; Lee YR; Kim KH; Im SA; Song S; Lee MK; Kim Y; Hong JT; Kim K; Lee CK
Int Immunopharmacol; 2011 Aug; 11(8):985-91. PubMed ID: 21354357
[TBL] [Abstract][Full Text] [Related]
27. Access of soluble antigens to the endoplasmic reticulum can explain cross-presentation by dendritic cells.
Ackerman AL; Kyritsis C; Tampé R; Cresswell P
Nat Immunol; 2005 Jan; 6(1):107-13. PubMed ID: 15592474
[TBL] [Abstract][Full Text] [Related]
28. Interactions of proteoliposomes from serogroup B Neisseria meningitidis with bone marrow-derived dendritic cells and macrophages: adjuvant effects and antigen delivery.
Rodríguez T; Pérez O; Ménager N; Ugrinovic S; Bracho G; Mastroeni P
Vaccine; 2005 Jan; 23(10):1312-21. PubMed ID: 15652674
[TBL] [Abstract][Full Text] [Related]
29. Neonatal and adult microglia cross-present exogenous antigens.
Beauvillain C; Donnou S; Jarry U; Scotet M; Gascan H; Delneste Y; Guermonprez P; Jeannin P; Couez D
Glia; 2008 Jan; 56(1):69-77. PubMed ID: 17932942
[TBL] [Abstract][Full Text] [Related]
30. Dendritic cell maturation enhances CD8+ T-cell responses to exogenous antigen via a proteasome-independent mechanism of major histocompatibility complex class I loading.
Robson NC; Beacock-Sharp H; Donachie AM; Mowat AM
Immunology; 2003 Jul; 109(3):374-83. PubMed ID: 12807483
[TBL] [Abstract][Full Text] [Related]
31. Dissociation of proteasomal degradation of biosynthesized viral proteins from generation of MHC class I-associated antigenic peptides.
Antón LC; Snyder HL; Bennink JR; Vinitsky A; Orlowski M; Porgador A; Yewdell JW
J Immunol; 1998 May; 160(10):4859-68. PubMed ID: 9590233
[TBL] [Abstract][Full Text] [Related]
32. Classical MHC class I peptide presentation of a bacterial fusion protein by bone marrow-derived dendritic cells.
Svensson M; Wick MJ
Eur J Immunol; 1999 Jan; 29(1):180-8. PubMed ID: 9933099
[TBL] [Abstract][Full Text] [Related]
33. Anatomic location defines antigen presentation by dendritic cells to T cells in response to intravenous soluble antigens.
Chung Y; Chang JH; Kim BS; Lee JM; Kim HY; Kang CY
Eur J Immunol; 2007 Jun; 37(6):1453-62. PubMed ID: 17474148
[TBL] [Abstract][Full Text] [Related]
34. Dendritic cell/macrophage precursors capture exogenous antigen for MHC class I presentation by dendritic cells.
Mitchell DA; Nair SK; Gilboa E
Eur J Immunol; 1998 Jun; 28(6):1923-33. PubMed ID: 9645374
[TBL] [Abstract][Full Text] [Related]
35. Peptide-receptive class I major histocompatibility complex molecules on TAP-deficient and wild-type cells and their roles in the processing of exogenous antigens.
Song R; Porgador A; Harding CV
Immunology; 1999 Jun; 97(2):316-24. PubMed ID: 10447748
[TBL] [Abstract][Full Text] [Related]
36. Dynamic quantification of MHC class I-peptide presentation to CD8+ T cells via intracellular cytokine staining.
Pang KC; Wei JQ; Chen W
J Immunol Methods; 2006 Apr; 311(1-2):12-8. PubMed ID: 16516224
[TBL] [Abstract][Full Text] [Related]
37. CpG-B ODNs potently induce low levels of IFN-alphabeta and induce IFN-alphabeta-dependent MHC-I cross-presentation in DCs as effectively as CpG-A and CpG-C ODNs.
Gray RC; Kuchtey J; Harding CV
J Leukoc Biol; 2007 Apr; 81(4):1075-85. PubMed ID: 17227820
[TBL] [Abstract][Full Text] [Related]
38. Characterization of antigen-presenting cells that present exogenous antigens in association with class I MHC molecules.
Rock KL; Rothstein L; Gamble S; Fleischacker C
J Immunol; 1993 Jan; 150(2):438-46. PubMed ID: 8419476
[TBL] [Abstract][Full Text] [Related]
39. Functional microtubules are required for antigen processing by macrophages and dendritic cells.
Peachman KK; Rao M; Palmer DR; Zidanic M; Sun W; Alving CR; Rothwell SW
Immunol Lett; 2004 Aug; 95(1):13-24. PubMed ID: 15325793
[TBL] [Abstract][Full Text] [Related]
40. The B subunit of Shiga toxin fused to a tumor antigen elicits CTL and targets dendritic cells to allow MHC class I-restricted presentation of peptides derived from exogenous antigens.
Haicheur N; Bismuth E; Bosset S; Adotevi O; Warnier G; Lacabanne V; Regnault A; Desaymard C; Amigorena S; Ricciardi-Castagnoli P; Goud B; Fridman WH; Johannes L; Tartour E
J Immunol; 2000 Sep; 165(6):3301-8. PubMed ID: 10975847
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
